
Journal of Medicinal Chemistry p. 2343 - 2349 (1993)
Update date:2022-08-05
Topics:
Kubo
Kohara
Yoshimura
Inada
Shibouta
Furukawa
Kato
Nishikawa
Naka
In order to improve the oral bioavailability (BA) of 2-butyl-1-[[2'-(1H- tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (3: CV-11194) and 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylic acid (
View Morewebsite:https://sdylchemical.com/
Contact:+86--13256654883
Address:Jinan Shandong
Contact:86-25-84683399
Address:605, Phoenix Herui Plaza, No.389, South Taiping Road, Nanjing, China 210002
Jewim Pharmaceutical (Shandong) Co., Ltd
Contact:+8615621883869
Address:山东省泰安市高新技术产业开发区配天门大街西首
jiangsu haian chemical co.,ltd.
Contact:86-513-15851283853
Address:No.99,Changjiang West Road,Haian County,Jiangsu Province,China
Wuhan Fortuna Chemical Co.,Ltd
website:http://www.fortunachem.com
Contact:86-27-59207850
Address:Add: Room 2015, No.2 Building, Kaixin Mansion No.107 Jinqiao Avenue, Wuhan, China
Doi:10.1002/hlca.19490320319
(1949)Doi:10.1021/jm00373a008
(1984)Doi:10.3390/antibiotics10040369
(2021)Doi:10.1016/j.bmc.2018.02.022
(2018)Doi:10.1039/b601804a
(2006)Doi:10.1021/jm060011o
(2006)